Longevity Goes Corporate — While Some Clients Ask to Put the Wearables Down

Tom Brady's eMed, now valued near $2 billion, is lobbying employers to add GLP-1 weight-loss drug coverage as a standard benefit, part of what Brady calls a push to "democratize health and wellness." The detail that matters for advisors isn't the drug — it's the budget shift underneath it. Corporate wellness spend is moving toward medically-supervised programs, the same demand pulling clients into SHA Wellness, Clinique La Prairie, and Mayrlife. Executive and corporate retreat packages that used to lean on spa treatments and nutrition coaching now compete with clinical add-ons: metabolic screening, GLP-1 management, physician follow-up. Advisors handling corporate incentive or executive-retreat accounts should confirm whether host properties can support or complement GLP-1 protocols, and consider positioning medically-supervised program tiers as a standard upsell rather than a niche request — especially for repeat corporate clients already asking about these benefits at home.

Real money is moving into skin-longevity science: Beiersdorf's new venture fund (over $100 million) and a $20 million raise for skincare startup Rapalogix both back treatments framed around cellular-aging research rather than conventional anti-aging marketing. Destination spas and longevity clinics are racing to add these protocols to their menus. But Global Wellness Institute's July trend coverage pairs the funding news with a caution: rising "longevity-washing," where unproven claims borrow the credibility of legitimate science. For advisors, that's a due-diligence cue before recommending or upselling skin-longevity treatments — ask properties what clinical evidence actually backs a given protocol before it lands in a client's itinerary. The opportunity is genuine, since this is where wellness-program investment is concentrating fastest, but the exposure is real too: recommending a treatment on marketing copy alone risks a client complaint when results don't match the pitch.

A counter-current is building against the biometric-tracking model many longevity retreats have leaned on for years. Global Wellness Summit's July trend roundup documents a real rise in clients who say they'd rather trust how their body feels than another wearable dashboard — not a fringe complaint, but a measurable sentiment shift. That's useful segmentation intel: retreat operators have spent recent years adding sleep trackers, sensors, and biomarker panels as a selling point, but a meaningful share of clients now want the opposite — unplugged, intuition-led programming without a daily data readout. A property built entirely around quantified biohacking may be the wrong match for these clients, even if it's otherwise longevity-focused. Worth raising directly in intake conversations before booking a heavily instrumented program on someone already signaling wearable fatigue, and worth keeping a short list of lower-tech retreat alternatives on hand for exactly this ask.